Showing results (771-780 of 3,921) with videos related to

Sort By:
Pageof 393
European Journal of Gynaecological Oncology|January 19, 2013
Correlated expression of Fas, NF-kappaB, and VEGF-C in infiltrating ductal carcinoma of the breastX L Dai, S L Zhou, J Qiu, et al.
European Journal of Gynaecological Oncology|January 19, 2013
Micro-metastases into the uterine leiomyoma from invasive ductal breast cancer under adjuvant tamoxifen therapy: case reportA Dirican, Y Kucukzeybek, I Somali, et al.
European Journal of Gynaecological Oncology|April 18, 2013
Invasive cancer of the cervix: does the UK National Health Service screening programme fail due to patients' non-attendance?K M Clement, D Mansour
European Journal of Gynaecological Oncology|April 18, 2013
HLA DRB allele polymorphisms and risk of cervical cancer associated with human papillomavirus infection: a population study in ChinaM Zhao, L Qiu, N Tao, et al.
European Journal of Gynaecological Oncology|April 18, 2013
Effects of volume-activated chloride channels on the invasion and migration of human endometrial cancer cellsM Li, D B Wu, J Wang
European Journal of Gynaecological Oncology|April 18, 2013
Characteristics and prognosis of ovarian metastatic tumors: review of a single-institution experienceV Ulker, C Numanoglu, V Alpay, et al.
European Journal of Gynaecological Oncology|April 18, 2013
Complete remission of recurrent and refractory ovarian cancers using weekly administration of bevacizumab and gemcitabine/oxaliplatin: report of two casesM Takano, Y Ikeda, K Kudoh, et al.
European Journal of Gynaecological Oncology|April 18, 2013
Perivascular epithelial cell tumor arising from polypoid adenomyoma: a case reportT Ishibashi, K Nakayama, N Nakayama, et al.
European Journal of Gynaecological Oncology|January 1, 1990
Individualization of indications for postoperative irradiation in stage I endometrial cancerJ V Bokhman, A Y Gastev
European Journal of Gynaecological Oncology|November 29, 2012
Comparison of outcomes in patients treated with multi-agent regiments of cisplatin, adriamycin, and VP-16 versus carboplatin and paclitaxel for advanced and recurrent endometrial cancerA B Olawaiye, H E Godoy, M M K Shahzad, et al.
Pageof 393